EASD 2007 43rd Annual Meeting of EASD
Amsterdam (The Netherlands), 17-21 settembre 2007
21 settembre
Clinical Trial Adding insulin to oral therapy
in type 2 diabetes
significantly improves glucose control but many patients
will need more than one type
of insulin
to achieve target glucose levels
Results of the 4-T trial presented at the 43rd European Association for the Study of Diabetes (EASD) meeting, Amsterdam, Holland Results from a UK study by Oxford University have shown that three different types of insulin all improve glucose control when added to oral therapy.
Insulin resistance, CV risk and physical activity Adiponectin, insulin resistance
and carotid thickening
The RISC study (Relationship between Insulin Sensitivity and Cardiovascular risk) is a European cohort designed to examine whether insulin resistance predicts cardiovascular disease.
Patient education Treatment adherence in type 2 diabetes
Diabetes is a largely self-managed condition, requiring the majority of patients to make significant lifestyle changes and adhere to medication prescriptions. It is well-recognised that clinical outcomes are strongly dependent on the patient’s daily self-care behaviours, including diet, exercise and medication taking.
Legal Disclaimer
Le affermazioni e le opinioni contenute nelle relazioni congressuali sono quelle degli Autori, e non vincolano in alcun modo le scelte editoriali di questo report congressuale, così che nessuna responsabilità di alcun tipo possa essere attribuita a CongressoMedico, a Infomedica o all'EASD. Talvolta gli studi presentati possono citare, a scopo informativo, prodotti non ancora approvati dalle competenti autorità; in qualsiasi caso, ogni prodotto menzionato deve essere utilizzato solo ed esclusivamente dalla Classe Medica in accordo con le schede tecniche fornite dalle Aziende produttrici.
